Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
Information query
Patent Agency Ranking
0/0